Mazdutide Consolidates Potential Efficacy Lead In China GLP-1 Obesity Race

 
• By Dexter Jie Yan
China obesity market
$5.5bn domestic market predicted for 2030 enticing Chinese developers of obesity drugs • Source: Shutterstock

More from Archive

More from Scrip